Economics and capital · venture-capital
Thyme Care, which focuses on filling gaps in cancer treatment through a virtual navigation platform, raised a $125M Series E at a $2B+ valuation (Ian Thomas/CNBC)
Thyme Care raised $125 million in a Series E round at a valuation exceeding $2 billion for its virtual cancer-treatment navigation platform.
Read the original at cnbc.comOpens the publisher's site in a new tabMore in Economics and capital
Nvidia agreed to acquire Hugging Face for approximately $12.93 billion while retaining its open-platform positioning.Sep 3Crusoe reportedly raised more than $3 billion at an approximately $30 billion valuation.Sep 4Alibaba announced a Hong Kong placement of 710 million new shares expected to raise approximately $10.2 billion.Sep 4Thailand suspended construction of 49 data centers while developing new industry regulations.Sep 4Wonderful raised $550 million in Series C funding at a $5 billion valuation.Sep 2